Economic Evaluation of Pharmaceuticals View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1993-09

AUTHORS

Michael Drummond, Frans Rutten, Antonio Brenna, Carlos Gouveia Pinto, Bruno Horisberger, Bengt Jönsson, Claude Le Pen, Joan Rovira, Matthias Graf von der Schulenburg, Harri Sintonen, Koen Torfs

ABSTRACT

In recent years there has been a large increase in the number of economic evaluations of pharmaceuticals. Many of these studies have been commissioned by individual pharmaceutical companies, in support of new or existing products. In 2 countries, Australia and Canada (in the province of Ontario), draft guidelines issued by the government have outlined the requirements for economic evaluations to be submitted in support of requests for reimbursement (government subsidy) of particular products. One consequence of the guidelines is that they clarify what is required, and in specifying the procedure for submission of dossiers, identify a clear audience for the economic evaluation. In contrast, the situation in Europe is diverse. A wide range of healthcare systems exist, including national health services and more liberal systems, involving a wide range of insurers and providers. European countries also differ widely in their approach to the pricing and reimbursement of pharmaceuticals. Because of this diversity, the nature, conduct and impact of economic evaluation in Europe is not clear. It is therefore difficult for pharmaceutical companies to develop appropriate strategies for economic evaluation and for analysts to decide on appropriate study methodology. This article reviews the nature of any official guidance or requirements for economic evaluation, the potential for use of economic evaluation, the range of studies carried out and the identifiable impacts. There is currently no official guidance in any country, although some countries are considering issuing guidelines. In some countries there is official encouragement to pharmaceutical companies to undertake studies, and where economic data have been presented they have been considered by the relevant committees. The potential uses of economic evaluation vary widely from country to country. These can be classified in terms of a potential role in undertaking national price negotiations, deciding on reimbursement status or copayment level, deciding on inclusion in local formularies or in treatment guidelines, or in improving prescribing decisions. Approximately 80 economic evaluations of pharmaceutical products have been conducted to date in Europe, covering a wide range of clinical areas. There are relatively few examples of identifiable effects of such studies. In part this is because it is often difficult to assess the part played by various items of data. Nevertheless, the overriding conclusion is that economic evaluation of medicines is likely to be more relevant in Europe in the future. The problem for the pharmaceutical industry is in determining when and how. More... »

PAGES

173-186

References to SciGraph publications

  • 1993-05. Guidelines for Economic Analysis of Pharmaceutical Products in PHARMACOECONOMICS
  • 1992-06. Australian Guidelines for Cost—Effectiveness Studies of Pharmaceuticals in PHARMACOECONOMICS
  • 1992-07. Cost-of-Illness Studies in PHARMACOECONOMICS
  • 1993-02. Misoprostol in PHARMACOECONOMICS
  • 1992-04. Recombinant Granulocyte Colony-Stimulating Factor (rG-CSF) in PHARMACOECONOMICS
  • 1992-08. The UK Indicative Prescribing Scheme in PHARMACOECONOMICS
  • 1992-01. Why a Journal of Pharmacoeconomics? in PHARMACOECONOMICS
  • 1992-01. Economic Evaluation of Drugs in PHARMACOECONOMICS
  • 1992-01. Economic Evaluation of Pharmaceuticals in PHARMACOECONOMICS
  • 1993-01. Epoetin in PHARMACOECONOMICS
  • 1992-01. Economic Analysis as an Aid to Subsidisation Decisions in PHARMACOECONOMICS
  • 1992-02. Simvastatin in PHARMACOECONOMICS
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.2165/00019053-199304030-00003

    DOI

    http://dx.doi.org/10.2165/00019053-199304030-00003

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1042196070

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/10146921


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1402", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Applied Economics", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/14", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Economics", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drug Industry", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Economics, Pharmaceutical", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Europe", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Forecasting", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "University of York", 
              "id": "https://www.grid.ac/institutes/grid.5685.e", 
              "name": [
                "Centre for Health Economics, University of York, 1 500, Heslington, York, England"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Drummond", 
            "givenName": "Michael", 
            "id": "sg:person.0735401715.46", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0735401715.46"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Erasmus University Rotterdam", 
              "id": "https://www.grid.ac/institutes/grid.6906.9", 
              "name": [
                "Institute for Medical Technology Assessment, Erasmus University, Rotterdam, The Netherlands"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Rutten", 
            "givenName": "Frans", 
            "id": "sg:person.01174260760.93", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174260760.93"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of Milan", 
              "id": "https://www.grid.ac/institutes/grid.4708.b", 
              "name": [
                "Istituto di Economia Sanitaria, Milan, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Brenna", 
            "givenName": "Antonio", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of Lisbon", 
              "id": "https://www.grid.ac/institutes/grid.9983.b", 
              "name": [
                "Instituto Superior de Economica e Gest\u00e3o, Universidade T\u00e9chnica de Lisboa, Lisbon, Portugal"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Pinto", 
            "givenName": "Carlos Gouveia", 
            "id": "sg:person.01212325711.96", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01212325711.96"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of St. Gallen", 
              "id": "https://www.grid.ac/institutes/grid.15775.31", 
              "name": [
                "Research Group for Management in Health Services, University of St Gallen, St Gallen, Switzerland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Horisberger", 
            "givenName": "Bruno", 
            "id": "sg:person.01123553330.01", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01123553330.01"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Stockholm School of Economics", 
              "id": "https://www.grid.ac/institutes/grid.419684.6", 
              "name": [
                "Stockholm School of Economics, Stockholm, Sweden"
              ], 
              "type": "Organization"
            }, 
            "familyName": "J\u00f6nsson", 
            "givenName": "Bengt", 
            "id": "sg:person.012641235562.41", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012641235562.41"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Paris Dauphine University", 
              "id": "https://www.grid.ac/institutes/grid.11024.36", 
              "name": [
                "LEGOS, Universit\u00e9 Paris-Dauphine, Paris, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Le Pen", 
            "givenName": "Claude", 
            "id": "sg:person.0753662054.70", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753662054.70"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of Barcelona", 
              "id": "https://www.grid.ac/institutes/grid.5841.8", 
              "name": [
                "SOIKOS and Universidad de Barcelona, Barcelona, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Rovira", 
            "givenName": "Joan", 
            "id": "sg:person.0771573732.99", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0771573732.99"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "name": [
                "Universit\u00e4t Hanover, Hanover, Federal Republic of Germany"
              ], 
              "type": "Organization"
            }, 
            "familyName": "von der Schulenburg", 
            "givenName": "Matthias Graf", 
            "id": "sg:person.016430657007.93", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016430657007.93"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of Eastern Finland", 
              "id": "https://www.grid.ac/institutes/grid.9668.1", 
              "name": [
                "Department of Health Policy and Management, University of Kuopio, Kuopio, Finland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Sintonen", 
            "givenName": "Harri", 
            "id": "sg:person.01331375373.75", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01331375373.75"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of Antwerp", 
              "id": "https://www.grid.ac/institutes/grid.5284.b", 
              "name": [
                "Bio-Pharma, Brussels, Belgium", 
                "Centre for Economic and Social Research, University of Antwerp, Antwerp, Belgium"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Torfs", 
            "givenName": "Koen", 
            "id": "sg:person.01147662530.91", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01147662530.91"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.2165/00019053-199303010-00006", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1004332399", 
              "https://doi.org/10.2165/00019053-199303010-00006"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1108/eb060549", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1006744707"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/00019053-199303020-00007", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1010708127", 
              "https://doi.org/10.2165/00019053-199303020-00007"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/00019053-199303050-00003", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1010943849", 
              "https://doi.org/10.2165/00019053-199303050-00003"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/00019053-199202010-00001", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1012528385", 
              "https://doi.org/10.2165/00019053-199202010-00001"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/00019053-199201010-00005", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013930198", 
              "https://doi.org/10.2165/00019053-199201010-00005"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1136/bmj.296.6615.99", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1014457550"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/00019053-199201010-00004", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1024178705", 
              "https://doi.org/10.2165/00019053-199201010-00004"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/00019053-199201040-00002", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1024281313", 
              "https://doi.org/10.2165/00019053-199201040-00002"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/00019053-199200011-00014", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1026135355", 
              "https://doi.org/10.2165/00019053-199200011-00014"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/00019053-199201010-00010", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028394779", 
              "https://doi.org/10.2165/00019053-199201010-00010"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/hec.4730010202", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1038394676"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/00019053-199201010-00002", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1044385080", 
              "https://doi.org/10.2165/00019053-199201010-00002"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/00019053-199201020-00009", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1044768504", 
              "https://doi.org/10.2165/00019053-199201020-00009"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/00019053-199202020-00006", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1048823654", 
              "https://doi.org/10.2165/00019053-199202020-00006"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1017/s0266462300002361", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1051650216"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1074444837", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1076430153", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1078518634", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.5694/j.1326-5377.1990.tb126189.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1078518634"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1993-09", 
        "datePublishedReg": "1993-09-01", 
        "description": "In recent years there has been a large increase in the number of economic evaluations of pharmaceuticals.  Many of these studies have been commissioned by individual pharmaceutical companies, in support of new or existing products.  In 2 countries, Australia and Canada (in the province of Ontario), draft guidelines issued by the government have outlined the requirements for economic evaluations to be submitted in support of requests for reimbursement (government subsidy) of particular products. One consequence of the guidelines is that they clarify what is required, and in specifying the procedure for submission of dossiers, identify a clear audience for the economic evaluation.  In contrast, the situation in Europe is diverse.  A wide range of healthcare systems exist, including national health services and more liberal systems, involving a wide range of insurers and providers.  European countries also differ widely in their approach to the pricing and reimbursement of pharmaceuticals.  Because of this diversity, the nature, conduct and impact of economic evaluation in Europe is not clear.  It is therefore difficult for pharmaceutical companies to develop appropriate strategies for economic evaluation and for analysts to decide on appropriate study methodology.  This article reviews the nature of any official guidance or requirements for economic evaluation, the potential for use of economic evaluation, the range of studies carried out and the identifiable impacts.  There is currently no official guidance in any country, although some countries are considering issuing guidelines.  In some countries there is official encouragement to pharmaceutical companies to undertake studies, and where economic data have been presented they have been considered by the relevant committees.  The potential uses of economic evaluation vary widely from country to country.  These can be classified in terms of a potential role in undertaking national price negotiations, deciding on reimbursement status or copayment level, deciding on inclusion in local formularies or in treatment guidelines, or in improving prescribing decisions.  Approximately 80 economic evaluations of pharmaceutical products have been conducted to date in Europe, covering a wide range of clinical areas.  There are relatively few examples of identifiable effects of such studies.  In part this is because it is often difficult to assess the part played by various items of data.  Nevertheless, the overriding conclusion is that economic evaluation of medicines is likely to be more relevant in Europe in the future.  The problem for the pharmaceutical industry is in determining when and how.", 
        "genre": "research_article", 
        "id": "sg:pub.10.2165/00019053-199304030-00003", 
        "inLanguage": [
          "en"
        ], 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1102812", 
            "issn": [
              "1170-7690", 
              "1179-2027"
            ], 
            "name": "PharmacoEconomics", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "3", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "4"
          }
        ], 
        "name": "Economic Evaluation of Pharmaceuticals", 
        "pagination": "173-186", 
        "productId": [
          {
            "name": "readcube_id", 
            "type": "PropertyValue", 
            "value": [
              "c90041a3152ad3eac8ad7fea61a9c69fd930055694c1250543a225c8e052e2da"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "10146921"
            ]
          }, 
          {
            "name": "nlm_unique_id", 
            "type": "PropertyValue", 
            "value": [
              "9212404"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.2165/00019053-199304030-00003"
            ]
          }, 
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1042196070"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.2165/00019053-199304030-00003", 
          "https://app.dimensions.ai/details/publication/pub.1042196070"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2019-04-11T02:24", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8700_00000569.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "http://link.springer.com/10.2165/00019053-199304030-00003"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.2165/00019053-199304030-00003'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.2165/00019053-199304030-00003'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.2165/00019053-199304030-00003'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.2165/00019053-199304030-00003'


     

    This table displays all metadata directly associated to this object as RDF triples.

    257 TRIPLES      21 PREDICATES      54 URIs      26 LITERALS      14 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.2165/00019053-199304030-00003 schema:about N16072cd95abc4d70ae47c04682971969
    2 N3760db2740174c8390bfc79eff6aa43c
    3 N572802c20603443bbb745f2b0186b6ec
    4 N97089eb31ca44253b23bb0e336b49370
    5 Nbfc40358fc054268b92d49b30594d9c1
    6 anzsrc-for:14
    7 anzsrc-for:1402
    8 schema:author N2e3d8d5f3765421884903501962cc605
    9 schema:citation sg:pub.10.2165/00019053-199200011-00014
    10 sg:pub.10.2165/00019053-199201010-00002
    11 sg:pub.10.2165/00019053-199201010-00004
    12 sg:pub.10.2165/00019053-199201010-00005
    13 sg:pub.10.2165/00019053-199201010-00010
    14 sg:pub.10.2165/00019053-199201020-00009
    15 sg:pub.10.2165/00019053-199201040-00002
    16 sg:pub.10.2165/00019053-199202010-00001
    17 sg:pub.10.2165/00019053-199202020-00006
    18 sg:pub.10.2165/00019053-199303010-00006
    19 sg:pub.10.2165/00019053-199303020-00007
    20 sg:pub.10.2165/00019053-199303050-00003
    21 https://app.dimensions.ai/details/publication/pub.1074444837
    22 https://app.dimensions.ai/details/publication/pub.1076430153
    23 https://app.dimensions.ai/details/publication/pub.1078518634
    24 https://doi.org/10.1002/hec.4730010202
    25 https://doi.org/10.1017/s0266462300002361
    26 https://doi.org/10.1108/eb060549
    27 https://doi.org/10.1136/bmj.296.6615.99
    28 https://doi.org/10.5694/j.1326-5377.1990.tb126189.x
    29 schema:datePublished 1993-09
    30 schema:datePublishedReg 1993-09-01
    31 schema:description In recent years there has been a large increase in the number of economic evaluations of pharmaceuticals. Many of these studies have been commissioned by individual pharmaceutical companies, in support of new or existing products. In 2 countries, Australia and Canada (in the province of Ontario), draft guidelines issued by the government have outlined the requirements for economic evaluations to be submitted in support of requests for reimbursement (government subsidy) of particular products. One consequence of the guidelines is that they clarify what is required, and in specifying the procedure for submission of dossiers, identify a clear audience for the economic evaluation. In contrast, the situation in Europe is diverse. A wide range of healthcare systems exist, including national health services and more liberal systems, involving a wide range of insurers and providers. European countries also differ widely in their approach to the pricing and reimbursement of pharmaceuticals. Because of this diversity, the nature, conduct and impact of economic evaluation in Europe is not clear. It is therefore difficult for pharmaceutical companies to develop appropriate strategies for economic evaluation and for analysts to decide on appropriate study methodology. This article reviews the nature of any official guidance or requirements for economic evaluation, the potential for use of economic evaluation, the range of studies carried out and the identifiable impacts. There is currently no official guidance in any country, although some countries are considering issuing guidelines. In some countries there is official encouragement to pharmaceutical companies to undertake studies, and where economic data have been presented they have been considered by the relevant committees. The potential uses of economic evaluation vary widely from country to country. These can be classified in terms of a potential role in undertaking national price negotiations, deciding on reimbursement status or copayment level, deciding on inclusion in local formularies or in treatment guidelines, or in improving prescribing decisions. Approximately 80 economic evaluations of pharmaceutical products have been conducted to date in Europe, covering a wide range of clinical areas. There are relatively few examples of identifiable effects of such studies. In part this is because it is often difficult to assess the part played by various items of data. Nevertheless, the overriding conclusion is that economic evaluation of medicines is likely to be more relevant in Europe in the future. The problem for the pharmaceutical industry is in determining when and how.
    32 schema:genre research_article
    33 schema:inLanguage en
    34 schema:isAccessibleForFree false
    35 schema:isPartOf N6514e34b63c94fdead77f3a775fa5c05
    36 Nf63b26290ea54ba5a63f2e2c28d71c4a
    37 sg:journal.1102812
    38 schema:name Economic Evaluation of Pharmaceuticals
    39 schema:pagination 173-186
    40 schema:productId N531f12817cba4e7090f6a380e8ab0c15
    41 N6c787aa9fae04347b3ff15a1917b79f3
    42 N73c24520988046b3affa68dd6e0595c9
    43 Nad8a25c713884489b45909818dd5fef5
    44 Ned202c8c616c46fab5698255ff2812d3
    45 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042196070
    46 https://doi.org/10.2165/00019053-199304030-00003
    47 schema:sdDatePublished 2019-04-11T02:24
    48 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    49 schema:sdPublisher Nf8835cf11b0b4d7b9a3063b722af6826
    50 schema:url http://link.springer.com/10.2165/00019053-199304030-00003
    51 sgo:license sg:explorer/license/
    52 sgo:sdDataset articles
    53 rdf:type schema:ScholarlyArticle
    54 N0906c60fec8b4a73bcc39878d20bd566 schema:name Universität Hanover, Hanover, Federal Republic of Germany
    55 rdf:type schema:Organization
    56 N16072cd95abc4d70ae47c04682971969 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    57 schema:name Forecasting
    58 rdf:type schema:DefinedTerm
    59 N1630db3d509e46b3a62ac91513c85240 rdf:first Nf379d7b258214ea79f1e0ece8b37e30e
    60 rdf:rest N8f3d68320d7f4973b8233678ff98b110
    61 N19c6ff345abc4005bb90809436d134b1 rdf:first sg:person.012641235562.41
    62 rdf:rest Nf78d8bdff0944a5d9716e32daff22215
    63 N2e3d8d5f3765421884903501962cc605 rdf:first sg:person.0735401715.46
    64 rdf:rest Na9c1e0343aa94b92939cd40b7f45e5f7
    65 N3760db2740174c8390bfc79eff6aa43c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    66 schema:name Drug Industry
    67 rdf:type schema:DefinedTerm
    68 N41d8c375a8754bf994f260237be89971 rdf:first sg:person.01123553330.01
    69 rdf:rest N19c6ff345abc4005bb90809436d134b1
    70 N531f12817cba4e7090f6a380e8ab0c15 schema:name pubmed_id
    71 schema:value 10146921
    72 rdf:type schema:PropertyValue
    73 N572802c20603443bbb745f2b0186b6ec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    74 schema:name Economics, Pharmaceutical
    75 rdf:type schema:DefinedTerm
    76 N6514e34b63c94fdead77f3a775fa5c05 schema:issueNumber 3
    77 rdf:type schema:PublicationIssue
    78 N6c787aa9fae04347b3ff15a1917b79f3 schema:name doi
    79 schema:value 10.2165/00019053-199304030-00003
    80 rdf:type schema:PropertyValue
    81 N73c24520988046b3affa68dd6e0595c9 schema:name readcube_id
    82 schema:value c90041a3152ad3eac8ad7fea61a9c69fd930055694c1250543a225c8e052e2da
    83 rdf:type schema:PropertyValue
    84 N774a25d53c2943de8d08fd00bcc493f6 rdf:first sg:person.01331375373.75
    85 rdf:rest Ncd29941296504435b0cf5b7c0a57ac01
    86 N77c95344d280413fa0afd9a4a244bac1 rdf:first sg:person.016430657007.93
    87 rdf:rest N774a25d53c2943de8d08fd00bcc493f6
    88 N8f3d68320d7f4973b8233678ff98b110 rdf:first sg:person.01212325711.96
    89 rdf:rest N41d8c375a8754bf994f260237be89971
    90 N97089eb31ca44253b23bb0e336b49370 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    91 schema:name Europe
    92 rdf:type schema:DefinedTerm
    93 Na9c1e0343aa94b92939cd40b7f45e5f7 rdf:first sg:person.01174260760.93
    94 rdf:rest N1630db3d509e46b3a62ac91513c85240
    95 Nad8a25c713884489b45909818dd5fef5 schema:name dimensions_id
    96 schema:value pub.1042196070
    97 rdf:type schema:PropertyValue
    98 Nad9161f05f0c43ca927535a7cf832485 rdf:first sg:person.0771573732.99
    99 rdf:rest N77c95344d280413fa0afd9a4a244bac1
    100 Nbfc40358fc054268b92d49b30594d9c1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    101 schema:name Humans
    102 rdf:type schema:DefinedTerm
    103 Ncd29941296504435b0cf5b7c0a57ac01 rdf:first sg:person.01147662530.91
    104 rdf:rest rdf:nil
    105 Ned202c8c616c46fab5698255ff2812d3 schema:name nlm_unique_id
    106 schema:value 9212404
    107 rdf:type schema:PropertyValue
    108 Nf379d7b258214ea79f1e0ece8b37e30e schema:affiliation https://www.grid.ac/institutes/grid.4708.b
    109 schema:familyName Brenna
    110 schema:givenName Antonio
    111 rdf:type schema:Person
    112 Nf63b26290ea54ba5a63f2e2c28d71c4a schema:volumeNumber 4
    113 rdf:type schema:PublicationVolume
    114 Nf78d8bdff0944a5d9716e32daff22215 rdf:first sg:person.0753662054.70
    115 rdf:rest Nad9161f05f0c43ca927535a7cf832485
    116 Nf8835cf11b0b4d7b9a3063b722af6826 schema:name Springer Nature - SN SciGraph project
    117 rdf:type schema:Organization
    118 anzsrc-for:14 schema:inDefinedTermSet anzsrc-for:
    119 schema:name Economics
    120 rdf:type schema:DefinedTerm
    121 anzsrc-for:1402 schema:inDefinedTermSet anzsrc-for:
    122 schema:name Applied Economics
    123 rdf:type schema:DefinedTerm
    124 sg:journal.1102812 schema:issn 1170-7690
    125 1179-2027
    126 schema:name PharmacoEconomics
    127 rdf:type schema:Periodical
    128 sg:person.01123553330.01 schema:affiliation https://www.grid.ac/institutes/grid.15775.31
    129 schema:familyName Horisberger
    130 schema:givenName Bruno
    131 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01123553330.01
    132 rdf:type schema:Person
    133 sg:person.01147662530.91 schema:affiliation https://www.grid.ac/institutes/grid.5284.b
    134 schema:familyName Torfs
    135 schema:givenName Koen
    136 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01147662530.91
    137 rdf:type schema:Person
    138 sg:person.01174260760.93 schema:affiliation https://www.grid.ac/institutes/grid.6906.9
    139 schema:familyName Rutten
    140 schema:givenName Frans
    141 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174260760.93
    142 rdf:type schema:Person
    143 sg:person.01212325711.96 schema:affiliation https://www.grid.ac/institutes/grid.9983.b
    144 schema:familyName Pinto
    145 schema:givenName Carlos Gouveia
    146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01212325711.96
    147 rdf:type schema:Person
    148 sg:person.012641235562.41 schema:affiliation https://www.grid.ac/institutes/grid.419684.6
    149 schema:familyName Jönsson
    150 schema:givenName Bengt
    151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012641235562.41
    152 rdf:type schema:Person
    153 sg:person.01331375373.75 schema:affiliation https://www.grid.ac/institutes/grid.9668.1
    154 schema:familyName Sintonen
    155 schema:givenName Harri
    156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01331375373.75
    157 rdf:type schema:Person
    158 sg:person.016430657007.93 schema:affiliation N0906c60fec8b4a73bcc39878d20bd566
    159 schema:familyName von der Schulenburg
    160 schema:givenName Matthias Graf
    161 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016430657007.93
    162 rdf:type schema:Person
    163 sg:person.0735401715.46 schema:affiliation https://www.grid.ac/institutes/grid.5685.e
    164 schema:familyName Drummond
    165 schema:givenName Michael
    166 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0735401715.46
    167 rdf:type schema:Person
    168 sg:person.0753662054.70 schema:affiliation https://www.grid.ac/institutes/grid.11024.36
    169 schema:familyName Le Pen
    170 schema:givenName Claude
    171 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753662054.70
    172 rdf:type schema:Person
    173 sg:person.0771573732.99 schema:affiliation https://www.grid.ac/institutes/grid.5841.8
    174 schema:familyName Rovira
    175 schema:givenName Joan
    176 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0771573732.99
    177 rdf:type schema:Person
    178 sg:pub.10.2165/00019053-199200011-00014 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026135355
    179 https://doi.org/10.2165/00019053-199200011-00014
    180 rdf:type schema:CreativeWork
    181 sg:pub.10.2165/00019053-199201010-00002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044385080
    182 https://doi.org/10.2165/00019053-199201010-00002
    183 rdf:type schema:CreativeWork
    184 sg:pub.10.2165/00019053-199201010-00004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024178705
    185 https://doi.org/10.2165/00019053-199201010-00004
    186 rdf:type schema:CreativeWork
    187 sg:pub.10.2165/00019053-199201010-00005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013930198
    188 https://doi.org/10.2165/00019053-199201010-00005
    189 rdf:type schema:CreativeWork
    190 sg:pub.10.2165/00019053-199201010-00010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028394779
    191 https://doi.org/10.2165/00019053-199201010-00010
    192 rdf:type schema:CreativeWork
    193 sg:pub.10.2165/00019053-199201020-00009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044768504
    194 https://doi.org/10.2165/00019053-199201020-00009
    195 rdf:type schema:CreativeWork
    196 sg:pub.10.2165/00019053-199201040-00002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024281313
    197 https://doi.org/10.2165/00019053-199201040-00002
    198 rdf:type schema:CreativeWork
    199 sg:pub.10.2165/00019053-199202010-00001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012528385
    200 https://doi.org/10.2165/00019053-199202010-00001
    201 rdf:type schema:CreativeWork
    202 sg:pub.10.2165/00019053-199202020-00006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048823654
    203 https://doi.org/10.2165/00019053-199202020-00006
    204 rdf:type schema:CreativeWork
    205 sg:pub.10.2165/00019053-199303010-00006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004332399
    206 https://doi.org/10.2165/00019053-199303010-00006
    207 rdf:type schema:CreativeWork
    208 sg:pub.10.2165/00019053-199303020-00007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010708127
    209 https://doi.org/10.2165/00019053-199303020-00007
    210 rdf:type schema:CreativeWork
    211 sg:pub.10.2165/00019053-199303050-00003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010943849
    212 https://doi.org/10.2165/00019053-199303050-00003
    213 rdf:type schema:CreativeWork
    214 https://app.dimensions.ai/details/publication/pub.1074444837 schema:CreativeWork
    215 https://app.dimensions.ai/details/publication/pub.1076430153 schema:CreativeWork
    216 https://app.dimensions.ai/details/publication/pub.1078518634 schema:CreativeWork
    217 https://doi.org/10.1002/hec.4730010202 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038394676
    218 rdf:type schema:CreativeWork
    219 https://doi.org/10.1017/s0266462300002361 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051650216
    220 rdf:type schema:CreativeWork
    221 https://doi.org/10.1108/eb060549 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006744707
    222 rdf:type schema:CreativeWork
    223 https://doi.org/10.1136/bmj.296.6615.99 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014457550
    224 rdf:type schema:CreativeWork
    225 https://doi.org/10.5694/j.1326-5377.1990.tb126189.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1078518634
    226 rdf:type schema:CreativeWork
    227 https://www.grid.ac/institutes/grid.11024.36 schema:alternateName Paris Dauphine University
    228 schema:name LEGOS, Université Paris-Dauphine, Paris, France
    229 rdf:type schema:Organization
    230 https://www.grid.ac/institutes/grid.15775.31 schema:alternateName University of St. Gallen
    231 schema:name Research Group for Management in Health Services, University of St Gallen, St Gallen, Switzerland
    232 rdf:type schema:Organization
    233 https://www.grid.ac/institutes/grid.419684.6 schema:alternateName Stockholm School of Economics
    234 schema:name Stockholm School of Economics, Stockholm, Sweden
    235 rdf:type schema:Organization
    236 https://www.grid.ac/institutes/grid.4708.b schema:alternateName University of Milan
    237 schema:name Istituto di Economia Sanitaria, Milan, Italy
    238 rdf:type schema:Organization
    239 https://www.grid.ac/institutes/grid.5284.b schema:alternateName University of Antwerp
    240 schema:name Bio-Pharma, Brussels, Belgium
    241 Centre for Economic and Social Research, University of Antwerp, Antwerp, Belgium
    242 rdf:type schema:Organization
    243 https://www.grid.ac/institutes/grid.5685.e schema:alternateName University of York
    244 schema:name Centre for Health Economics, University of York, 1 500, Heslington, York, England
    245 rdf:type schema:Organization
    246 https://www.grid.ac/institutes/grid.5841.8 schema:alternateName University of Barcelona
    247 schema:name SOIKOS and Universidad de Barcelona, Barcelona, Spain
    248 rdf:type schema:Organization
    249 https://www.grid.ac/institutes/grid.6906.9 schema:alternateName Erasmus University Rotterdam
    250 schema:name Institute for Medical Technology Assessment, Erasmus University, Rotterdam, The Netherlands
    251 rdf:type schema:Organization
    252 https://www.grid.ac/institutes/grid.9668.1 schema:alternateName University of Eastern Finland
    253 schema:name Department of Health Policy and Management, University of Kuopio, Kuopio, Finland
    254 rdf:type schema:Organization
    255 https://www.grid.ac/institutes/grid.9983.b schema:alternateName University of Lisbon
    256 schema:name Instituto Superior de Economica e Gestão, Universidade Téchnica de Lisboa, Lisbon, Portugal
    257 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...